Loading…
Nutriband Inc. is projected to rise to $4.22 by 2027, a +24% move from its current price of $3.41. NTRB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.31 | $3.41 | $3.50 | +0.03% |
| May 30 | $3.28 | $3.41 | $3.54 | +0.05% |
| May 31 | $3.25 | $3.41 | $3.58 | +0.08% |
| Jun 1 | $3.22 | $3.41 | $3.60 | +0.11% |
| Jun 2 | $3.20 | $3.41 | $3.63 | +0.13% |
| Jun 3 | $3.19 | $3.41 | $3.65 | +0.16% |
| Jun 4 | $3.17 | $3.41 | $3.67 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.17 | $3.41 | $3.67 | +0.18% |
| Week 2 | $3.08 | $3.42 | $3.79 | +0.37% |
| Week 3 | $3.02 | $3.42 | $3.89 | +0.55% |
| Week 4 | $2.96 | $3.43 | $3.97 | +0.74% |
| Week 5 | $2.92 | $3.44 | $4.05 | +0.92% |
| Week 6 | $2.88 | $3.44 | $4.12 | +1.11% |
| Week 7 | $2.84 | $3.45 | $4.19 | +1.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nutriband Inc. is a healthcare company focused on developing transdermal pharmaceutical products in the United States. Its lead product in development is AVERSA fentanyl, an abuse-deterrent fentanyl transdermal system designed to provide clinicians and patients with an extended-release fentanyl product for chronic pain requiring around-the-clock opioid therapy.
The company also develops AVERSA buprenorphine and AVERSA methylphenidate, along with other transdermal pharmaceutical products. It has a commercial development and clinical supply agreement with Kindeva Drug Delivery. Nutriband was incorporated in 2016 and is headquartered in Orlando, Florida.
Nutriband Inc. (NTRB) is a Healthcare sector stock with a current price of $3.64 and a market capitalization of $44.25M, ranking 4647 by market cap.
The 30-day price range is $3.03 to $4.37, and the technical picture shows a bearish overall tone with RSI(14) at 50, SMA50 at $3.82, and SMA200 at $5.17. Immediate support sits at $3.42 and resistance at $4.30. The stock exhibits about 50% annualized volatility.
Forecasts indicate a bullish trajectory beyond 2026, with the average price rising from $3.64 in 2026 toward higher levels by 2050 and a progressively larger ROI, culminating in a 2050 average price of $18.84 and a max of $35.08 with a 417.7% ROI.
A major floor 17.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 26.3% above — a clean break opens room to run.
A major ceiling 46.0% above — clearing it would confirm fresh momentum.
Key NTRB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NTRB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.51 | Sell | $3.49 | Sell |
| MA 10 | $3.51 | Sell | $3.54 | Sell |
| MA 20 | $3.66 | Sell | $3.64 | Sell |
| MA 50 | $3.80 | Sell | $3.83 | Sell |
| MA 100 | $4.07 | Sell | $4.19 | Sell |
| MA 200 | $5.13 | Sell | $4.79 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.99 | Neutral |
| Stoch RSI (14) | 28.88 | Neutral |
| CCI (20) | -112.24 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -9.20 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.39 | Sell |
| Awesome (5,34) | -0.30 | Sell |
| Ultimate (7,14,28) | 34.18 | Neutral |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 3.51 | Sell |
| ADX (14) | 16.20 | Neutral |
| ATR (14) | 0.10 | Info |
The 30-day technical picture shows a bearish sentiment with RSI(14) at 50. The stock is trading near its SMA levels, with SMA50 listed at $3.82 and SMA200 at $5.17, suggesting near-term pressure versus longer-term upside.
The 30-day range stretches from a low of $3.03 to a high of $4.37, with a nearby support level at $3.42 and resistance at $4.30. This setup implies limited downside risk around the support zone but potential resistance near the $4.30 level in the short term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.40 | $3.41 | $4.20 | 0% | Neutral | |
| $3.34 | $4.22 | $5.65 | +24% | Bullish | |
| $3.63 | $4.71 | $6.53 | +38% | Bullish | |
| $3.56 | $4.73 | $6.75 | +39% | Bullish | |
| $3.73 | $5.05 | $7.39 | +48% | Bullish | |
| $3.66 | $5.06 | $7.56 | +49% | Bullish | |
| $3.64 | $5.11 | $7.79 | +50% | Bullish | |
| $3.88 | $5.55 | $8.59 | +63% | Bullish | |
| $4.56 | $6.62 | $10.43 | +95% | Bullish | |
| $5.09 | $7.50 | $11.98 | +120% | Bullish | |
| $5.92 | $9.33 | $15.86 | +174% | Bullish | |
| $8.97 | $15.93 | $29.63 | +368% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.40 | $3.41 | $3.99 | +0.00% |
| June 2026 | $2.92 | $3.43 | $4.13 | +0.85% |
| July 2026 | $2.94 | $3.49 | $4.25 | +1.56% |
| August 2026 | $2.82 | $3.36 | $4.14 | -3.70% |
| September 2026 | $2.71 | $3.26 | $4.05 | -3.06% |
| October 2026 | $2.77 | $3.34 | $4.18 | +2.51% |
| November 2026 | $2.79 | $3.38 | $4.26 | +1.17% |
| December 2026 | $2.72 | $3.31 | $4.20 | -1.97% |
Click any year to see its month-by-month NTRB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NTRB to range from $3.40 to $4.20 through 2026. The $3.41 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The NTRB price prediction for 2027 points to an average of $4.22 (low $3.34, high $5.65) — a potential gain of +24% on today's $3.41. Momentum favours further upside here.
In 2028, NTRB is projected to trade between $3.63 and $6.53, averaging $4.71 — a potential gain of +38% from today's $3.41. That is up +11% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Nutriband Inc.'s 2029 outlook centres on $4.73, within a $3.56 to $6.75 range. That is up 0% on the projected 2028 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2030, NTRB could reach as high as $7.39, with a base case around $5.05 and support toward $3.73 — roughly +48% from $3.41. Buyers look set to stay in control over this stretch.
Expect NTRB to range from $3.66 to $7.56 through 2031. The $5.06 average target implies a +49% move from current prices. That is up 0% on the projected 2030 average. Momentum favours further upside here.
The NTRB price prediction for 2032 points to an average of $5.11 (low $3.64, high $7.79) — a potential gain of +50% on today's $3.41. Buyers look set to stay in control over this stretch.
In 2033, NTRB is projected to trade between $3.88 and $8.59, averaging $5.55 — a potential gain of +63% from today's $3.41. That is up +8% on the projected 2032 average. Momentum favours further upside here.
Nutriband Inc.'s 2034 outlook centres on $6.62, within a $4.56 to $10.43 range. That is up +19% on the projected 2033 average. That marks a +95% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, NTRB could reach as high as $11.98, with a base case around $7.50 and support toward $5.09 — roughly +120% from $3.41. Momentum favours further upside here.
Expect NTRB to range from $5.92 to $15.86 through 2040. The $9.33 average target implies a +174% move from current prices. That is up +24% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The NTRB price prediction for 2050 points to an average of $15.93 (low $8.97, high $29.63) — a potential gain of +368% on today's $3.41. Momentum favours further upside here.
Investing $1,000 in NTRB today (≈ 293.685756 NTRB) could be worth
$4,677.05
+$3,677.05 (+368%) by 2050 · US Dollar
Based on the average projected NTRB price of $15.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NTRBwould be worth at today's price.
$1,000 invested in NTRB on May 27, 2025 (≈ 167.22408 NTRB) would be worth
$569.4
-$430.6 (-43.1%) today · 0.57× · US Dollar
Based on a NTRB entry price of $5.98 vs. today's $3.41.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.53 | $964.59 | -3.5% |
| 1 month ago | $3.89 | $875.32 | -12.5% |
| 3 months ago | $4.31 | $790.02 | -21.0% |
| 6 months ago | $4.95 | $688.57 | -31.1% |
| 1 year ago | $5.98 | $569.4 | -43.1% |
| All time (4.7y) ago | $5.74 | $593.46 | -40.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NTRB forecast.
Our base-case forecast reaches $6.80 around 2035.
Implied market cap at $6.80: $82.66M
The multi-year forecast paints a bullish path with rising average prices and higher ROI after 2026. The 2027 forecast shows an avg of $4.68 with a 28.6% ROI; 2028, avg $5.18 and 42.2% ROI; 2029, avg $5.21 and 43.1% ROI; 2030, avg $5.67 and 55.9% ROI, continuing through 2031 ($5.66, 55.6%), 2032 ($5.76, 58.3%), 2033 ($6.44, 76.8%), 2034 ($7.65, 110.1%), and 2035 ($8.61, 136.6%). The outlook remains bullish into 2040 (avg $10.99, ROI 202) and 2050 (avg $18.84, max $35.08, ROI 417.7%).
These projections reflect a steady rise in the average price over time and sizable upside potential, but they are not guarantees and depend on market and company-specific developments. Risks include market fluctuations and changes in conditions that could alter price trajectories.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $5.67 with a max of $8.30 and a min of $4.18, along with a 55.9% ROI. The sentiment is BULLISH.
The forecast shifts to BULLISH from 2027 onward, with rising average prices and positive ROI (e.g., 2027 avg $4.68, ROI 28.6%; 2030 avg $5.67, ROI 55.9%; 2050 avg $18.84, ROI 417.7%). 2026 is Neutral, and outcomes are not guaranteed.
Yes—the 2050 forecast max is $35.08, with a 2050 average of $18.84 and a 417.7% ROI, indicating substantial potential upside under the projection.
The current price is $3.64 and the market capitalization is $44.25M. The stock ranks 4647 by market cap.
The 30-day range is between $3.03 and $4.37.
Nutriband Inc. Community Discussion
0Share your Nutriband Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.